Novelix Pharmaceuticals Ltd
536565 · Healthcare · Healthcare Research, Analytics & Technology
- Market cap
- Rs 184 Cr
- P/E
- —
- P/B
- 24.41x
- 52W high / low
- —
Stored market cap (1.8375e+09) diverges from price x shares outstanding (6.2289e+13) by >3x; likely a stale or share-count-corrupted figure. Our computed roe (-1.98%) diverges from BSE's own published figure (40.40%) by more than 100%. BSE's figure is a different, BSE-computed number (not necessarily TTM, standalone-only) — treat as a cross-check/fallback signal, not proof either figure is wrong. Our computed operating_margin (-11.29%) diverges from BSE's own published figure (3.52%) by more than 100%. BSE's figure is a different, BSE-computed number (not necessarily TTM, standalone-only) — treat as a cross-check/fallback signal, not proof either figure is wrong. Our computed net_margin (-10.25%) diverges from BSE's own published figure (3.19%) by more than 100%. BSE's figure is a different, BSE-computed number (not necessarily TTM, standalone-only) — treat as a cross-check/fallback signal, not proof either figure is wrong.
More
Peer comparison
Official BSE basic industry: Healthcare Research, Analytics & Technology. Limited to companies within a 0.1x–10x market-cap band.
Edit columns
| Vimta Labs Limited | Rs 617 | Rs 1,371 Cr | Rs 339 Cr | Rs 61.4 Cr | 46.29x | 20.41% |
| TAKE Limited | Rs 23.76 | Rs 351 Cr | Rs 92.5 Cr | Rs 12.8 Cr | 60.92x | 49.76% |
| Novelix Pharmaceuticals LtdThis company | Rs 76.9 | Rs 184 Cr | Rs 6.7 Cr | Rs -0.6 Cr | — | -1.98% |
| Bilcare Limited | Rs 76.81 | Rs 181 Cr | Rs 799 Cr | Rs -13.3 Cr | — | 2.33% |
| Jeevan Scientific Technology Ltd | Rs 80.25 | Rs 161 Cr | Rs 71.8 Cr | Rs 5.1 Cr | 27.77x | 8.40% |
| Globalspace Technologies Ltd | Rs 29.71 | Rs 102 Cr | Rs 57.8 Cr | Rs 3.4 Cr | 31.61x | 6.10% |
| Adeshwar Meditex Ltd | Rs 16.8 | Rs 24.2 Cr | — | — | 19.09x | — |
| Median | Rs 54.98 | Rs 132 Cr | Rs 71.8 Cr | Rs 5.1 Cr | 29.69x | 8.40% |
Peers are selected mechanically from the official BSE industry hierarchy and current market-cap band. This is a comparison set, not a ranking or recommendation.